Decision Analysis Supports the Paradigm That Indiscriminate Supplementation of Vitamin E Does More Harm than Good
Authors:
- 1 September 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 29 (9) , 1304-1309
Abstract
Objectives— For many years, the prevailing concept was that LDL oxidation plays a central role in atherogenesis. As a consequence, supplementation of antioxidants, particularly vitamin E, became very popular. Unfortunately, however, the major randomized clinical trials have yielded disappointing results on the effects of vitamin E on both mortality and morbidity. Moreover, recent meta-analyses have concluded that vitamin E supplementation increases mortality. This conclusion has raised much criticism, most of it relating to three issues: (1) the choice of clinical trials to be included in the meta-analyses; (2) the end point of these meta-analyses (only mortality); and (3) the heterogeneity of the analyzed clinical trials with respect to both population and treatment. Our goal was to bring this controversy to an end by using a Markov-model approach, which is free of most of the limitations involved in using meta-analyses. Methods and Results— We used a Markov model to compare the vitamin E supplemented virtual cohorts with nonsupplemented cohorts derived from published randomized clinical trials that were included in at least one of the major meta-analyses. The difference between the virtual supplemented and nonsupplemented cohorts is given in terms of a composite end point denoted quality-adjusted life year (QALY). The vitamin E supplemented virtual cohort had 0.30 QALY (95%CI 0.21 to 0.39) less than the nontreated virtual cohort. Conclusions— Our study demonstrates that in terms of QALY, indiscriminate supplementation of high doses of vitamin E is not beneficial in preventing CVD. Selective supplementation of vitamin E to individuals under oxidative stress requires further investigation.Keywords
This publication has 43 references indexed in Scilit:
- Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 GenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007
- Recent Developments in Decision-Analytic Modelling for Economic EvaluationPharmacoEconomics, 2006
- Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysisThe Lancet, 2004
- The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?Trends in Cardiovascular Medicine, 2001
- Using the years-of-healthy-life measure to calculate QALYsAmerican Journal of Preventive Medicine, 2001
- Primer on Medical Decision Analysis: Part 5—Working with Markov ProcessesMedical Decision Making, 1997
- Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and UtilitiesMedical Decision Making, 1997
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986